BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22773129)

  • 1. Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).
    Halter JP; van Walraven SM; Worel N; Bengtsson M; Hägglund H; Nicoloso de Faveri G; Shaw BE; Schmidt AH; Fechter M; Madrigal A; Szer J; Aljurf MD; Weisdorf D; Horowitz MM; Greinix H; Niederwieser D; Gratwohl A; Kodera Y; Confer D
    Bone Marrow Transplant; 2013 Feb; 48(2):220-5. PubMed ID: 22773129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association.
    Bitan M; van Walraven SM; Worel N; Ball LM; Styczynski J; Torrabadella M; Witt V; Shaw BE; Seber A; Yabe H; Greinix HT; Peters C; Gluckman E; Rocha V; Halter J; Pulsipher MA
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):96-103. PubMed ID: 26307344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.
    Worel N; Buser A; Greinix HT; Hägglund H; Navarro W; Pulsipher MA; Nicoloso de Faveri G; Bengtsson M; Billen A; Espino G; Fechter M; Giudice V; Hölig K; Kanamori H; Kodera Y; Leitner G; Netelenbos T; Niederwieser D; van Walraven SM; Rocha V; Torosian T; Vergueiro C; Weisdorf D; Yabe H; Halter JP
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2052-2060. PubMed ID: 26271194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donors.
    Rinaldi C; Savignano C; Pasca S; Sperotto A; Patriarca F; Isola M; Fanin R; De Angelis V
    Transfusion; 2012 Nov; 52(11):2387-94. PubMed ID: 22452363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of bone marrow stem cell donation: a review.
    Bosi A; Bartolozzi B
    Transplant Proc; 2010; 42(6):2192-4. PubMed ID: 20692441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The methods used to collect hematopoietic stem cells].
    Hequet O
    Transfus Clin Biol; 2011 Apr; 18(2):230-4. PubMed ID: 21397542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
    Keil F; Prinz E; Moser K; Mannhalter C; Kalhs P; Worel N; Rabitsch W; Schulenburg A; Mitterbauer M; Greinix H
    Transplantation; 2003 Jul; 76(1):230-6. PubMed ID: 12865815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rules and French regulations for blood and marrow stem cell donation].
    Jouet JP
    Rev Prat; 2008 Dec; 58(19):2105-10. PubMed ID: 19213538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood stem cell procurement: donor safety issues.
    Anderlini P; Przepiorka D; Körbling M; Champlin R
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S35-9. PubMed ID: 9712491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change.
    Christopeit M; Kuss O; Finke J; Bacher U; Beelen DW; Bornhäuser M; Schwerdtfeger R; Bethge WA; Basara N; Gramatzki M; Tischer J; Kolb HJ; Uharek L; Meyer RG; Bunjes D; Scheid C; Martin H; Niederwieser D; Kröger N; Bertz H; Schrezenmeier H; Schmid C
    J Clin Oncol; 2013 Sep; 31(26):3259-71. PubMed ID: 23918951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term donor health and its relationship with outcome of allogeneic hematopoietic stem cell transplantation.
    Au WY; Lie AK; Cheng JW; Liang R; Kwong YL
    Bone Marrow Transplant; 2006 Mar; 37(5):451-3. PubMed ID: 16415890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products.
    Hurley CK; Foeken L; Horowitz M; Lindberg B; McGregor M; Sacchi N;
    Bone Marrow Transplant; 2010 May; 45(5):819-24. PubMed ID: 20173794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptance and feasibility of peripheral stem cell mobilisation compared to bone marrow collection from healthy unrelated donors.
    Ordemann R; Hölig K; Wagner K; Rautenberg U; Bornhäuser M; Kroschinsky F; Schäfer J; Schuler U; Ehninger G
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S25-8. PubMed ID: 9712488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO).
    Majolino I; Cavallaro AM; Bacigalupo A; Rambaldi A; Falda M; Locatelli F; Raimondi R; Pucci G; Mordini N; Barbui T; Locatelli F; Rodeghiero F; Irrera G; Indovina A; Valbonesi M; Bellavita P; Tassi V; Perotti C; Soli M; Bresolin G
    Haematologica; 1997; 82(1):47-52. PubMed ID: 9107082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program.
    Bolan CD; Hartzman RJ; Perry EH; Trainor L; Miller J; Miller R; Hanley L; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):23-8. PubMed ID: 18721777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.
    Pulsipher MA; Nagler A; Iannone R; Nelson RM
    Pediatr Blood Cancer; 2006 Apr; 46(4):422-33. PubMed ID: 16411207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic peripheral blood stem cell transplantation.
    Spitzer TR
    J Infus Chemother; 1996; 6(1):33-8. PubMed ID: 8748005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Umbilical cord blood as a source of stem cells].
    Bojanić I; Golubić Cepulić B
    Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation.
    Al-Ali HK; Bourgeois M; Krahl R; Edel E; Leiblein S; Poenisch W; Basara N; Lange T; Niederwieser D
    Bone Marrow Transplant; 2011 Oct; 46(10):1296-302. PubMed ID: 21132022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.